Abstract:Cardiac fibrosis accompanies numerous cardiovascular diseases (CVD) such as hypertension and myocardial infarction and increases myocardial stiffness leading to contractile dysfunction. Recently, endothelial-to-mesenchymal transition (EndMT) has been shown to contribute to myocardial fibrosis. EndMT describes a process by which endothelial cells transform into mesenchymal cells such as fibroblasts and has been implicated in many fibrotic diseases. Angiotensin II (AngII) plays a key role in myocardial fibrosis and has been associated with the activation of fibroblasts to myofibroblasts and an increase in myocardial collagen deposition. Here, we assessed the role of AngII in capillary loss and EndMT in vivo and in vitro . C57BL/6J mice were infused with H 2 O (control) or 24μg/kg/hr AngII for 4 weeks. Mice infused with AngII developed significant cardiac fibrosis characterised by the deposition of collagen I (2.5-fold vs. control; p<0.05) and III (1.9-fold vs. control; p<0.05). Capillary density was assessed by CD31 immunohistochemistry and revealed significant vascular rarefaction (control 2161±111 vs . AngII 838±132 capillaries/mm 2 ; p<0.05). To investigate whether AngII can induce EndMT in vitro , human coronary artery endothelial cells were stimulated with 10ng/mL TGFβ 1 alone or in combination with 1μM AngII for 10 days. AngII significantly enhanced TGFβ 1 -induced gene expression of α-smooth muscle actin (TGFβ 1 1.8-fold; TGFβ 1 ±AngII 4.3-fold vs . control; p<0.05) and collagen I (TGFβ 1 9.2-fold; TGFβ 1 +AngII 30.2-fold vs . control; p<0.05). Concomitantly, AngII significantly increased α-smooth muscle actin protein expression (TGFβ 1 3.9-fold; TGFβ 1 +AngII 23.6-fold vs . control; p<0.05) and significantly decreased CD31 expression (TGFβ 1 0.9-fold; TGFβ 1 +AngII 0.7-fold vs . control; p<0.05), suggesting AngII acts in concert with TGFβ 1 to enhance conversion of endothelial cells to myofibroblasts. Further studies investigating the underlying mechanism, including the role of the Smad pathway, are ongoing. These results demonstrate that AngII induces vascular rarefaction in vivo and potentiates TGFβ 1 -induced EndMT in vitro. Understanding the molecular basis for these observations may help to identify new therapeutic options in CVD.

Activin A Stimulates the Proliferation and Differentiation of Cardiac Fibroblasts Via the ERK1/2 and P38-Mapk Pathways

Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts.

Activin A As A Novel Chemokine Induces Migration Of L929 Fibroblasts By Erk Signaling In Microfluidic Devices

Effects of angiotensin-(1-7) on the proliferation and collagen synthesis of arginine vasopressin-stimulated rat cardiac fibroblasts: role of mas receptor-calcineurin-NF-κB signaling pathway.

Activin A Inhibition Attenuates Sympathetic Neural Remodeling Following Myocardial Infarction in Rats

The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation

[Effect and Potential Mechanism of Β3-Adrenoceptor Activation on Fibrosis in Cardiac Fibroblast Cell].

Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis

Angiotensin II Upregulates KCa3.1 Channels and Stimulates Cell Proliferation in Rat Cardiac Fibroblasts

Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.

AMP-activated Kinase Activation Inhibits Transforming Growth Factor-Β1 Production in Cardiac Fibroblasts Via Targeting C/EBPβ

Activin A Activation Drives Renal Fibrosis Through the STAT3 Signaling Pathway.

Improving Vagal Activity Ameliorates Cardiac Fibrosis Induced by Angiotensin Ii: in Vivo and in Vitro

Effects of the Activin A-Follistatin System on Myocardial Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway in Heart Failure

Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61

Mitogenic Effect of Arginine Vasopressin on Adult Rat Cardiac Fibroblast: Involvement of PKC-erk1/2 Pathway.

Ghrelin Suppresses Cardiac Fibrosis of Post-Myocardial Infarction Heart Failure Rats by Adjusting the Activin A-follistatin Imbalance

Abstract MP02: Angiotensin II Mediates Microvascular Rarefaction In Vivo and Exacerbates Endothelial-To-Mesenchymal Transition In Vitro

Partial Inhibition Of Activin Receptor-Like Kinase 4 Attenuates Pressure Overload-Induced Cardiac Fibrosis And Improves Cardiac Function

Antagonistic Effects of Activin A and TNF-α on the Activation of L929 Fibroblast Cells Via Smad3-independent Signaling

Haplodeficiency of Activin Receptor-Like Kinase 4 Alleviates Myocardial Infarction-Induced Cardiac Fibrosis and Preserves Cardiac Function